National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen–Based Screening
- 1 August 2015
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 33 (22), 2416-2423
- https://doi.org/10.1200/jco.2015.61.6532
Abstract
In 2012, the US Preventive Services Task Force (USPSTF) discouraged prostate-specific antigen (PSA) –based prostate cancer screening. Previous USPSTF recommendations did not appreciably alter prostate cancer screening. Therefore, we designed a trend analysis to determine the population-based impact of the 2012 recommendation. The nationally representative National Health Interview Survey was used to estimate the proportion of men age 40 years and older who saw a physician and were screened for prostate cancer in 2013. An externally validated 9-year mortality index was used to analyze screening rates based on remaining life expectancy. Screening rates from 2005, 2010, and 2013 were compared using logistic regression. PSA-based screening did not significantly change from 2010 to 2013 among 40- to 49-year-old men (from 12.5% to 11.2%; P = .4). Screening rates significantly declined in men age 50 to 59 years (from 33.2% to 24.8%; P < .01), age 60 to 74 years (from 51.2% to 43.6%; P < .01), and age 75 years or older (from 43.9% to 37.1%; P = .03). A large percentage of men were screened for prostate cancer despite a high risk (> 52%) of 9-year mortality, including approximately one third of men older than age 75 years. Approximately 1.4 million men age 65 years or older with a high risk (> 52%) of 9-year mortality were screened in 2013. Prostate cancer screening significantly declined among men older than age 50 years after the 2012 USPSTF guideline discouraging PSA-based screening. A significant proportion of men continue to be screened despite a high risk of 9-year mortality, including one third of men age 75 years and older.Keywords
This publication has 37 references indexed in Scilit:
- Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of PhysiciansAnnals of Internal Medicine, 2013
- Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2012
- Prostate specific antigen screening for prostate cancer: Knowledge of, attitudes towards, and utilization among primary care physiciansUrologic Oncology: Seminars and Original Investigations, 2012
- Population-Based Patterns and Predictors of Prostate-Specific Antigen Screening Among Older Men in the United StatesJournal of Clinical Oncology, 2011
- American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010CA: A Cancer Journal for Clinicians, 2010
- Prostate Cancer Early DetectionJournal of the National Comprehensive Cancer Network, 2010
- Prostate Specific Antigen Best Practice Statement: 2009 UpdateJournal of Urology, 2009
- Mortality Results from a Randomized Prostate-Cancer Screening TrialNew England Journal of Medicine, 2009
- Screening and Prostate-Cancer Mortality in a Randomized European StudyNew England Journal of Medicine, 2009
- Screening for Prostate Cancer in U.S. Men: ACPM Position Statement on Preventive PracticeAmerican Journal of Preventive Medicine, 2008